Royal Emerald Pharmaceuticals
Royal Emerald Pharmaceuticals: Developing safe, non-addictive alternative medicines for society's heroes.
Founded
2017Royal Emerald Pharmaceuticals: Developing safe, non-addictive alternative medicines for society's heroes.
Founded with a mission to develop safe and non-addictive alternative medicines, Royal Emerald Pharmaceuticals focuses on creating therapeutic solutions that avoid harmful side effects and addiction. The company is dedicated to the health and well-being of its consumers, particularly veterans and first responders. Their product offerings include botanical drug manufacturing, specifically DEA Schedule I bulk manufacturing of marijuana, cannabinoid isolates, and distillates, all in compliance with Title 21 of the CFR. They also provide extensive research and development services in partnership with top academic institutions.
Royal Emerald Pharmaceuticals has garnered attention for its commitment to producing non-addictive medications, a significant achievement in the pharmaceutical industry. The company collaborates with leading researchers and institutions to advance its mission. While specific investors and notable affiliated individuals are not detailed, the company's impact is evident in its focus on providing safer medicinal alternatives for those who have served their communities. This dedication positions Royal Emerald Pharmaceuticals as a key player in the development of plant-based therapeutics.
Companies similar to Royal Emerald Pharmaceuticals include Emerald Health Pharmaceuticals, Emerald Health Bioceuticals, The Emerald and Elite Pharmaceuticals.
Royal Emerald Pharmaceuticals was founded in 2017.
Royal Emerald Pharmaceuticals' headquarters is located in Desert Hot Springs, CA, US.
Royal Emerald Pharmaceuticals' most recent funding round was for $17M (USD) in March 2022.
As of Mar 8, 2022, Royal Emerald Pharmaceuticals has raised a total of $17M (USD).
Royal Emerald Pharmaceuticals has 375 employees as of Feb 4, 2024.
The Emerald
theemeraldcorp.com
